Taysha Gene Therapies, Inc. - TSHA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | President and Head of R&D | M | D | 19,021.0 | 0.0 | 0.0 | 455,920.0 | View | |
| Apr 13, 2026 | President and Head of R&D | S | D | 200,000.0 | 4.46 | 892,000.0 | 1,136,410.0 | View | |
| Apr 13, 2026 | President and Head of R&D | M | A | 19,021.0 | 1.71 | 32,525.91 | 1,336,410.0 | View | |
| Feb 06, 2026 | CHIEF FINANCIAL OFFICER | S | D | 1,655.0 | 4.52 | 7,480.6 | 1,442,131.0 | View | |
| Jan 27, 2026 | President and Head of R&D | S | D | 26,918.0 | 4.61 | 124,091.98 | 1,317,389.0 | View | |
| Jan 27, 2026 | President and Head of R&D | S | D | 89,132.0 | 4.75 | 423,377.0 | 1,344,307.0 | View | |
| Jan 27, 2026 | Chief Executive Officer | S | D | 41,312.0 | 4.61 | 190,448.32 | 2,908,257.0 | View | |
| Jan 27, 2026 | Chief Executive Officer | S | D | 136,789.0 | 4.75 | 649,747.75 | 2,949,569.0 | View | |
| Jan 27, 2026 | CHIEF FINANCIAL OFFICER | S | D | 23,849.0 | 4.61 | 109,943.89 | 1,443,786.0 | View | |
| Jan 27, 2026 | CHIEF FINANCIAL OFFICER | S | D | 78,968.0 | 4.75 | 375,098.0 | 1,467,635.0 | View | |
| Jan 14, 2026 | CHIEF FINANCIAL OFFICER | A | A | 231,000.0 | 0.0 | 0.0 | 231,000.0 | View | |
| Jan 14, 2026 | CHIEF FINANCIAL OFFICER | A | A | 359,000.0 | 0.0 | 0.0 | 1,546,603.0 | View | |
| Jan 14, 2026 | Chief Executive Officer | A | A | 648,000.0 | 0.0 | 0.0 | 648,000.0 | View | |
| Jan 14, 2026 | Chief Executive Officer | A | A | 1,008,000.0 | 0.0 | 0.0 | 3,086,358.0 | View | |
| Jan 14, 2026 | President and Head of R&D | A | A | 274,000.0 | 0.0 | 0.0 | 274,000.0 | View | |
| Jan 14, 2026 | President and Head of R&D | M | D | 88,676.0 | 0.0 | 0.0 | 474,941.0 | View | |
| Jan 14, 2026 | President and Head of R&D | M | D | 111,324.0 | 0.0 | 0.0 | 111,359.0 | View | |
| Jan 14, 2026 | President and Head of R&D | A | A | 427,000.0 | 0.0 | 0.0 | 1,433,439.0 | View | |
| Jan 14, 2026 | President and Head of R&D | S | D | 200,000.0 | 4.71 | 942,000.0 | 1,006,439.0 | View | |
| Jan 14, 2026 | President and Head of R&D | M | A | 88,676.0 | 1.71 | 151,635.96 | 1,206,439.0 | View | |
| Jan 14, 2026 | President and Head of R&D | M | A | 111,324.0 | 0.6989 | 77,804.34 | 1,117,763.0 | View | |
| Dec 01, 2025 | President and Head of R&D | M | D | 260,047.0 | 0.0 | 0.0 | 563,617.0 | View | |
| Dec 01, 2025 | President and Head of R&D | M | D | 39,953.0 | 0.0 | 0.0 | 823,664.0 | View | |
| Dec 01, 2025 | President and Head of R&D | M | D | 70,172.0 | 0.0 | 0.0 | 222,683.0 | View | |
| Dec 01, 2025 | President and Head of R&D | S | D | 260,047.0 | 4.51 | 1,172,811.97 | 1,006,439.0 | View | |
| Dec 01, 2025 | President and Head of R&D | M | A | 260,047.0 | 1.71 | 444,680.37 | 1,266,486.0 | View | |
| Dec 01, 2025 | President and Head of R&D | S | D | 110,125.0 | 4.75 | 523,093.75 | 1,006,439.0 | View | |
| Dec 01, 2025 | President and Head of R&D | M | A | 39,953.0 | 1.71 | 68,319.63 | 1,116,564.0 | View | |
| Dec 01, 2025 | President and Head of R&D | M | A | 70,172.0 | 0.6989 | 49,043.21 | 1,076,611.0 | View |